Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients
- 24 October 2006
- journal article
- clinical trial
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 14 (6), 387-391
- https://doi.org/10.1111/j.1365-2893.2006.00806.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2005
- Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected PatientsA Randomized Controlled TrialJAMA, 2004
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patientsAIDS, 2004
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected PatientsNew England Journal of Medicine, 2004
- Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Dynamics during HCV Treatment in HCV/HIV CoinfectionThe Journal of Infectious Diseases, 2003
- Effect of ribavirin on hepatitis C viral kinetics in patients treated with pegylated interferonHepatology, 2003
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Increasing Impact of Chronic Viral Hepatitis on Hospital Admissions and Mortality among HIV-Infected PatientsAIDS Research and Human Retroviruses, 2001
- Increasing Mortality Due to End-Stage Liver Disease in Patients with Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2001
- Hepatitis C Virus Infection as an Opportunistic Disease in Persons Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 2000